Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001279569-06-000809
Filing Date
2006-07-21
Accepted
2006-07-20 18:13:23
Documents
3
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A aspreva10k.htm 10-K/A 109035
2 CERTIFICATE OF PRINCIPAL EXECUTIVE OFFICER ex311.htm EX-31.1 8000
3 CERTIFICATE OF PRINCIPAL FINANCIAL OFFICER ex312.htm EX-31.2 7997
  Complete submission text file 0001279569-06-000809.txt   126441
Mailing Address 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8
Business Address 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8 (250) 744-2488
Aspreva Pharmaceuticals CORP (Filer) CIK: 0001314026 (see all company filings)

EIN.: 980435540 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51169 | Film No.: 06972618
SIC: 2834 Pharmaceutical Preparations